Target intelligence / Profile preview

Ribosomal protein L8 pseudogene 2 (RPL8P2)

Target
RPL8P2
Molecular classification
Other (processed pseudogene), Not a protein-coding gene
01

Overview

Ribosomal protein L8 pseudogene 2 (RPL8P2) is annotated as a human pseudogene, meaning it closely resembles the functional ribosomal protein L8 (RPL8) gene but is not itself protein-coding[2][4]. It does not produce a functional protein and is therefore not considered a therapeutic or pharmacologic target. The main gene, RPL8, encodes a structural component of the 60S ribosomal subunit with known roles in protein synthesis and in certain diseases. In contrast, RPL8P2 has not been attributed biological function, disease relevance, or clinical utility[2][4]. No drugs target RPL8P2, and there are no issues related to biomarkers or safety because it is not a protein or functional RNA product. The main potential confusion comes from similarity to the canonical RPL8 gene, which is functionally relevant, but RPL8P2 itself is a processed pseudogene without a demonstrated role in cellular or disease processes[2][4].

Other names
RPL8P2
02

Biological functions

no known biological function; pseudogene
03

Disease associations

no established disease role; pseudogene

Beyond the preview

Go deeper on Ribosomal protein L8 pseudogene 2 (RPL8P2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L8 pseudogene 2 (RPL8P2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call